[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.112.64. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 4, 1991

Unsuspected Osteomyelitis in Diabetic Foot UlcersDiagnosis and Monitoring by Leukocyte Scanning With Indium In 111 Oxyquinoline

Author Affiliations

From the Department of Medicine, Division of Endocrinology and Metabolism (Drs Newman, Roman, and Stagnaro-Gree); Department of Surgery, Division of Orthopedic Surgery (Dr Waller) and Division of Vascular Surgery (Drs Schwartz, E. Harrington, and M. Harrington); Department of Nuclear Medicine (Dr Palestro); Department of Pathology (Dr Klein); and Department of Radiology (Dr Hermann), Mount Sinai Medical Center, New York, NY.

From the Department of Medicine, Division of Endocrinology and Metabolism (Drs Newman, Roman, and Stagnaro-Gree); Department of Surgery, Division of Orthopedic Surgery (Dr Waller) and Division of Vascular Surgery (Drs Schwartz, E. Harrington, and M. Harrington); Department of Nuclear Medicine (Dr Palestro); Department of Pathology (Dr Klein); and Department of Radiology (Dr Hermann), Mount Sinai Medical Center, New York, NY.

JAMA. 1991;266(9):1246-1251. doi:10.1001/jama.1991.03470090080036
Abstract

Objective.  —The prevalence of osteomyelitis in diabetic foot ulcers is unknown. Early diagnosis of this infection is critical, as prompt antibiotic treatment decreases the rate of amputation. We therefore assessed the prevalence of osteomyelitis in 35 diabetic patients with 41 foot ulcers. We compared results of roentgenograms, leukocyte scans with indium In 111 oxyquinoline, and bone scans with the diagnostic criterion standards of bone histologic and culture findings. Leukocyte scans were repeated at 2- to 3-week intervals during antibiotic treatment.

Design.  —Cohort study.

Setting.  —Institutional and private, ambulatory and hospitalized patients.

Patients.  —Consecutive sample of 54 diabetic patients. Thirty-five patients with 41 foot ulcers were included.

Results.  — As determined by bone biopsy and culture, osteomyelitis was found to underlie 28 (68%) of 41 diabetic foot ulcers. Only nine (32%) of the 28 cases were diagnosed clinically by the referring physician. Underscoring the clinically silent nature of osteomyelitis in these ulcers, 19 (68%) of 28 occurred in outpatients, 19 (68%) of 28 occurred in ulcers not exposing bone, and 18 (64%) of 28 had no evidence of inflammation on physical examination. All patients with ulcers that exposed bone had osteomyelitis. Of the imaging tests, the leukocyte scan had the highest sensitivity, 89%. In patients with osteomyelitis, the leukocyte scan image intensity decreased by 16 to 34 days of antibiotic treatment and normalized by 36 to 54 days.

Conclusion.  —The majority of diabetic foot ulcers have an underlying osteomyelitis that is clinically unsuspected. Leukocyte scans are highly sensitive for diagnosing osteomyelitis in diabetic foot ulcers and may be useful for monitoring the efficacy of antibiotic treatment. We recommend that diabetic patients with foot ulcers that expose bone should be treated for osteomyelitis. Diabetic patients with foot ulcers that do not expose bone should undergo leukocyte scanning, which eliminates the risk of bone biopsy in diagnosing osteomyelitis and allows for the diagnosis and treatment of this well-known but often silent precursor of lower extremity amputation.(JAMA. 1991;266:1246-1251)

×